HB1720 104TH GENERAL ASSEMBLY

LRB104 03276 RLC 13298 b

104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
HB1720

Introduced 1/28/2025, by Rep. Amy Elik

SYNOPSIS AS INTRODUCED:

New Act

Creates the Retail Sale of Tianeptine Prohibition Act. Provides that beginning January 1, 2026, no person shall sell, offer to sell, or distribute in the State any product containing tianeptine. Provides that the Act does not apply to any product containing tianeptine that is lawfully dispensed or prescribed by a pharmacist or a health care professional. Provides that a violation is a business offense, punishable by a minimum fine of $1,500 for each violation. Defines "health care professional". Effective January 1, 2026.

A BILL FOR

AN ACT concerning criminal law.

Be it enacted by the People of the State of Illinois, represented in the General Assembly:

Section 1. Short title. This Act may be cited as the Retail Sale of Tianeptine Prohibition Act.

Section 5. Retail sale of tianeptine products.

(a) Beginning January 1, 2026, no person shall sell, offer to sell, or distribute in the State any product containing tianeptine.

(b) This Act does not apply to any product containing tianeptine that is lawfully dispensed or prescribed by a pharmacist or a health care professional. In this subsection (b), "health care professional" means any person who treats human ailments and is subject to licensure or regulation by this State, including students and residents.

Section 10. Sentence. A violation of Section 5 is a business offense, punishable by a minimum fine of $1,500 for each violation.

Section 99. Effective date. This Act takes effect January 1, 2026.